Health

Displaying 1 - 6 of 207

Interviews & Viewpoints | Fahad Al Shebel, CEO, National Unified Procurement Company (NUPCO): Interview from The Report: Saudi Arabia 2022

Fahad Al Shebel, CEO, National Unified Procurement Company (NUPCO)

Considering the impact of the Covid-19 pandemic, which strategies are expected to underpin the development of the local health sector?

Read article

Interviews & Viewpoints | Hisham bin Saad Aljadhey, CEO, Saudi Food and Drug Authority (SFDA): Interview from The Report: Saudi Arabia 2022

Hisham bin Saad Aljadhey, CEO, Saudi Food and Drug Authority (SFDA)

To what extent has the Covid-19 pandemic impacted medical innovation and related regulatory processes in Saudi Arabia?

Read article

Interviews & Viewpoints | Moussa Diaby, Director-General, Institut National Polytechnique Félix Houphouët-Boigny: Interview from The Report: Cote d'Ivoire 2022

Moussa Diaby, Director-General, Institut National Polytechnique Félix Houphouët-Boigny

In which sectors could research and development (R&D) efforts have the greatest impact?

Read article

Interviews & Viewpoints | Pierre Dimba, Minister of Health, Public Hygiene and Universal Health Coverage: Interview from The Report: Cote d'Ivoire 2022

Pierre Dimba, Minister of Health, Public Hygiene and Universal Health Coverage

 

How will the ministry work to strengthen the health sector in the coming years?

Read article

Interviews & Viewpoints | Delese Mimi Darko, CEO, Food and Drugs Authority (FDA): Interview from The Report: Ghana 2022

Delese Mimi Darko, CEO, Food and Drugs Authority (FDA)

 

What was the role of the FDA in the approval process for Covid-19 vaccines?

Read article

Interviews & Viewpoints | Moji Adeyeye, Director-General, National Agency for Food and Drug Administration and Control (NAFDAC): Interview from The Report: Nigeria 2022

In what ways did NAFDAC contribute to the country’s Covid-19 vaccine rollout?

Read article

Covid-19 Economic Impact Assessments

Stay updated on how some of the world’s most promising markets are being affected by the Covid-19 pandemic, and what actions governments and private businesses are taking to mitigate challenges and ensure their long-term growth story continues.

Register now and also receive a complimentary 2-month licence to the OBG Research Terminal.

Register Here×

Product successfully added to shopping cart